Abstract:Background Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease of which the pathogenesis remains largely unknown. Many factors could influence COPD development and progression. One of them is the genetic risk factor. A severe hereditary deficiency of alpha-1 antitrypsin is the best genetic proof. Four single nucleotide polymorphisms (SNPs) of beta2-adrenergic receptor (beta(2)AR) result in single amino acid substitution. Two loci had been extensively studied and found that they could change the function of beta(2)AR. Two SNPs consist of substitutions of glycine for arginine at amino acid position 16, glutamic acid for glutamine at position 27. Many studies proved that polymorphisms at position 16 and 27 altered the lung function of COPD patients or the patient's susceptibility to the development of COPD. However, there was no exclusive conclusion. Therefore, a meta analysis was done to investigate the effect of polymorphisms in the beta 2-adrenergic receptor (ADRB2) gene on the risk of COPD and lung function. Methods Comprehensive searches of MEDLINE, Embase, Ovid, HighWire, Cochrane Library, and Chinese databases (CBMdisc, VIP, CNKI, and Wanfang data) from January 1980 to September 2011 were performed, using the keywords: COPD OR chronic obstructive pulmonary disease AND adrenoreceptor OR adrenergic receptor AND polymorphism OR mutation OR variation. Case-control research or cross sectional studies in which diagnosis of COPD met the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines; all the studies reported the ADRB2 genotype at position 16 or 27. Outcomes measured were genotype frequency and forced expiratory volume in the first second (FEV1%) in both the case and control. Results Twelve case-control studies and eight cross-sectional studies were included. Compared to the control (n=1225), neither Gly/Gly (n=527) nor Arg/Arg (n=422) homozygotes at position 16 demonstrated increased susceptibility to COPD, with odds ratios (ORs) of 0.95 (95% CI (0.68, 1.31), z=0.33, P=0.740) and 0.82 (95% CI (0.52, 1.28), z=0.88, P=0.381), respectively. Similar results were obtained for position 27, with ORs of 0.97 (95% CI (0.77, 1.23), z=0.21, P=0.833) for Glu/Glu homozygotes (n=357) and 0.82 (95% CI (0.53, 1.29), z=0.85, P=0.393) for Gln/Gln homozygotes (n=704) (control=1183). In patients with COPD, Arg/Arg homozygotes (n=41) had a similar FEV1% compared with Gly/Gly homozygotes (n=102) (standardized mean difference (SMD)=0.88, 95% CI (-0.85, 2.62), z=1.00, P=0.319). The genotype distribution was different between Caucasian and Asian populations (all P <0.05 except the genotype Arg/Gly) for both position 16 and 27. Conclusions Polymorphisms of ADRB2 at positions 16 and 27 did not change the risk of COPD nor affect lung function or disease severity. The genotype distribution for these polymorphisms was different between Caucasian and Asian populations. Chin Med J 2012;125(12):2213-2218

A Disintegrin and Metalloprotease 33 Gene Polymorphisms and the Risk of Chronic Obstructive Pulmonary Disease:A Meta-analysis

Polymorphisms in a disintegrin and metalloprotease 33 gene and the risk of chronic obstructive pulmonary disease: a meta-analysis.

Association of a Disintegrin and Metalloproteinase 33 (ADAM33) Gene Polymorphisms with Chronic Obstructive Pulmonary Disease in the Chinese Population: a Meta-Analysis.

Association Between ADAM 33 Gene Polymorphism and Chronic Obstructive Pulmonary Disease

Study of the association between a disintegrin and metalloprotease 19 gene polymorphisms and chronic obstructive pulmonary disease susceptibility

ADAM33 Gene Polymorphism Is Correlated with Airway Inflammation of COPD

Association of ADAM33 Gene Polymorphisms with COPD in the Mongolian Population of China.

Association Between the ADAM33 Gene Polymorphism and Bronchial Asthma

A disintegrin and metalloprotease 33 (ADAM33) gene polymorphisms and the risk of asthma: a meta-analysis.

Association of the FAM 13 A rs 7671167 polymorphism with COPD risk : a meta-analysis

Association Between The Tumour Necrosis Factor-Alpha -308g/A Polymorphism And Chronic Obstructive Pulmonary Disease: An Update

Genetic Polymorphism of Matrix Metalloproteinase Family and Chronic Obstructive Pulmonary Disease Susceptibility: a Meta-analysis

[Association Between Interleukin-1B Polymorphisms and Chronic Obstructive Pulmonary Disease: a Meta-Analysis].

Study on Relationship Between Genetic Polymorphisms of ADAM33 and Susceptibility to Bronchial Asthma

Interleukin-1β gene polymorphisms and the susceptivity to chronic obstructive pulmonary disease: a systematic review

ADAM33 Gene Polymorphisms Associate with Asthma Susceptibility and Severity in East China Han Population.

Effect of polymorphisms in the beta 2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis

Association Between Beta 2-Adrenergic Receptor-16arg/Gly Gene Polymorphism And Chronic Obstructive Pulmonary Disease Risk: Systematic Review And Meta-Analysis

A Correlational Meta-Analytical Study of Transforming Growth Factor-Β Genetic Polymorphisms As a Risk Factor for Chronic Obstructive Pulmonary Disease.

Interleukin-1B-31T/C Promoter Polymorphism and Chronic Obstructive Pulmonary Disease Risk: a Meta-Analysis.

Association of Gene Polymorphisms of Tumour Necrosis Factor-Alpha and Interleukin-13 with Chronic Obstructive Pulmonary Disease in Han Nationality in Beijing.